Richard Giltner - Net Worth and Insider Trading

Richard Giltner Net Worth

The estimated net worth of Richard Giltner is at least $884,813 dollars as of 2024-04-26. Richard Giltner is the Director of United Therapeutics Corp and owns about 3,750 shares of United Therapeutics Corp (UTHR) stock worth over $884,813. Details can be seen in Richard Giltner's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Richard Giltner has not made any transactions after 2020-04-20 and currently still holds the listed stock(s).

Transaction Summary of Richard Giltner

To

Richard Giltner Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Richard Giltner owns 1 companies in total, including United Therapeutics Corp (UTHR) .

Click here to see the complete history of Richard Giltner’s form 4 insider trades.

Insider Ownership Summary of Richard Giltner

Ticker Comapny Transaction Date Type of Owner
UTHR United Therapeutics Corp 2020-06-26 director

Richard Giltner Latest Holdings Summary

Richard Giltner currently owns a total of 1 stock. Richard Giltner owns 3,750 shares of United Therapeutics Corp (UTHR) as of April 20, 2020, with a value of $884,813.

Latest Holdings of Richard Giltner

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
UTHR United Therapeutics Corp 2020-04-20 3,750 235.95 884,813

Holding Weightings of Richard Giltner


Richard Giltner Form 4 Trading Tracker

According to the SEC Form 4 filings, Richard Giltner has made a total of 7 transactions in United Therapeutics Corp (UTHR) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in United Therapeutics Corp is the sale of 5,000 shares on April 20, 2020, which brought Richard Giltner around $535,000.

Insider Trading History of Richard Giltner

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Richard Giltner Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Richard Giltner Ownership Network

Ownership Network List of Richard Giltner

No Data

Ownership Network Relation of Richard Giltner


Richard Giltner Owned Company Details

What does United Therapeutics Corp do?

Who are the key executives at United Therapeutics Corp?

Richard Giltner is the director of United Therapeutics Corp. Other key executives at United Therapeutics Corp include director & Chief Executive Officer Martine A Rothblatt , EVP & General Counsel Paul A Mahon , and President and COO Michael Benkowitz .

United Therapeutics Corp (UTHR) Insider Trades Summary

Over the past 18 months, Richard Giltner made no insider transaction in United Therapeutics Corp (UTHR). Other recent insider transactions involving United Therapeutics Corp (UTHR) include a net sale of 1,325,285 shares made by Martine A Rothblatt , a net sale of 206,500 shares made by Paul A Mahon , and a net sale of 1,977 shares made by Nilda Mesa .

In summary, during the past 3 months, insiders sold 442,290 shares of United Therapeutics Corp (UTHR) in total and bought 0 shares, with a net sale of 442,290 shares. During the past 18 months, 1,562,002 shares of United Therapeutics Corp (UTHR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,562,002 shares.

United Therapeutics Corp (UTHR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

United Therapeutics Corp Insider Transactions

No Available Data

Richard Giltner Mailing Address

Above is the net worth, insider trading, and ownership report for Richard Giltner. You might contact Richard Giltner via mailing address: C/o United Therapeutics Corportion, 1735 Connecticut Ave. Nw, Washington Dc 20009.

Discussions on Richard Giltner

No discussions yet.